We conducted a mutation profile analysis of the TCGA-BLCA cohort and found that RYR3, FAT3, and VCAN were the three most significantly mutated genes (Supplementary Fig. S5). This evidence concerns the gene FAT3 and bladder transitional cell carcinoma.